Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Efficacy of Diet on Quality of Life in Multiple Sclerosis
NCT05007483 · View on ClinicalTrials.gov ↗
Study Summary
The overarching goal of this project is to critically evaluate the efficacy of incorporating dietary guidance within multiple sclerosis (MS) care for improving long-term quality of life (QoL) compared to usual care. The primary objective of this study is to evaluate the effect of two dietary interventions (time restricted olive oil based (TROO) ketogenic and modified Paleolithic elimination) on MS QoL compared to usual care control (Dietary Guidelines for America), and the secondary objectives and the long-term effects on, motor function, low-contrast vision sensitivity, fatigue, mood, and disease activity assessed by brain imaging.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT BodyBio Balance Oil
- DIETARY_SUPPLEMENT Kirunal Fish Oil
- DIETARY_SUPPLEMENT BodyBio PC
- BEHAVIORAL Modified Paleolithic Elimination diet
- BEHAVIORAL Time Restricted Olive Oil Based (TROO) Ketogenic Diet
Study Locations (1)
Iowa
- Univeristy of Iowa — Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2022-02-10 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05007483
The ClinicalTrials.gov registry entry for NCT05007483 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Terry L. Wahls, which has 31 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Multiple Sclerosis, Relapsing-Remitting appearing as the primary indexed condition, and to 5 interventions — of which BodyBio Balance Oil is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05007483 reports 1 study location spanning 1 distinct geographic area — top geographies include Iowa. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05007483 about?
NCT05007483 is a clinical study titled "Efficacy of Diet on Quality of Life in Multiple Sclerosis". The overarching goal of this project is to critically evaluate the efficacy of incorporating dietary guidance within multiple sclerosis (MS) care for improving long-term quality of life (QoL) compared to usual care. The primary objective of this study is to evaluate the effect of two dietary interve...
What is the current status of trial NCT05007483?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2022-02-10. Estimated completion is 2026-12-01.
What conditions does trial NCT05007483 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Relapsing-Remitting. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05007483?
The interventions under investigation include: BodyBio Balance Oil (DIETARY_SUPPLEMENT), Kirunal Fish Oil (DIETARY_SUPPLEMENT), BodyBio PC (DIETARY_SUPPLEMENT), Modified Paleolithic Elimination diet (BEHAVIORAL), Time Restricted Olive Oil Based (TROO) Ketogenic Diet (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05007483?
This trial is sponsored by Terry L. Wahls, which has 31 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05007483 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.